OBSTETRICAL PROBLEMS IN PREGNANT WOMEN WITH METABOLIC SYNDROME
https://doi.org/10.29235/1814-6023-2018-15-2-151-159
Abstract
The characteristics of the gestation and the condition of newborns by 156 pregnant women with metabolic syndrome (MS) were studied. It was identified that the pregnancy course of patients with MS has frequently been complicated by the progression of gestational hypertensive disorders, chronic placental inadequacy, and gestational diabetes. Taking into account a high risk of intranatal complications, the patients’ preparation of parturition with the birth activity induction was made more often. Among the abdominal delivery were the leading positions of a scar on the womb after the cliohysterectomy in previous parturition and a long-term history of infertility. The patients with MS were observed to have a high rate of descent birth activity, placental inadequacy decomposition. The post-natal period of the patients with MS has frequently been complicated by the womb subinvolution. The children, born by mothers with MS, are characterized by a higher body mass index at birth, a higher proportion of the hypoxic and ishemic damaged central nervous system.
About the Authors
A. Y. Zakharko
Republican Scientific Center for Radiation Medicine and Human Ecology.
Belarus
Belarus
Anna Y. Zakharko – obstetrician-gynecologist.
290, Iliich Str., 246040, Gomel.
N. P. Mitkovskaya
Belarusian State Medical University.
Belarus
Belarus
Natalya P. Mitkovskaya – D. Sc. (Med.), Professor, Head of the Department.
83, Dzerzhynskiy Ave., 220116, Minsk.
O. K. Doronina
Belarusian State Medical University.
Belarus
Belarus
Olga K. Doronina – D. Sc. (Med.), Professor, Vice-Rector.
83, Dzerzhynskiy Ave., 220116, Minsk.
References
1. Khromylev A. V. Metabolic syndrome and pregnancy. Ozhirenie i metabolism [Obesity and Metabolism], 2014, no. 2, pp. 3-7. (in Russian).
2. Satalano P., de Mouzon S. H. Maternal obesity and metabolic risk to the offspring: why lifestyle interventions may have not achieved the desired outcomes. International Journal of Obesity, vol. 39, no. 4, pp. 642-649. DOI: 10.1038/ ijo.2015.15
3. Vryonidou A., Paschou S. A., Muscogiuri G., Orio F., Goulis D. G. Mechanisms in endocrinology: metabolic syndrome through the female life cycle. European Journal of , 2015, vol. 173, no. 5, pp. 153-163. DOI: 10.1530/EJE-150275
4. Song Y., Gao J., Qu Y., Wang S., Wang X., Liu J. Serum levels of leptin, adiponectin and resistin in relation to clinical characteristics in normal pregnancy and preeclampsia. Clinica Chimica ,2016, vol. 458, pp. 133-137. DOI: 10.1016/j. cca.2016.04.036
5. Kovaleva Yu. V. Hormones of adipose tissue and their role in the formation of hormonal status and the pathogenesis of metabolic disorders in women. Arterial’naya gipertenziya = Arterial hypertension, 2015, vol. 21, no. 4, pp. 356-370 (in Russian).
6. Blüher M., Mantzoros C. S. From leptin to other adipokines in healh and disease: facts expectations at the beginning 21st century. Metabolism, 2015, vol. 64, no. 1, pp. 131-145. DOI: 10.1016/j.metabol.2014.10.016
7. Pérez-Pérez A., Sánchez-Jiménez F., Maymó J., Dueñas J. L., Varone C., Sánchez-Margalet V. Role of leptin in female reproduction. Clinical Chemistry and Laboratory , 2015, vol. 53, no. 1, pp. 15-28. DOI: 10.1515/cclm-2014-0387
8. Chabanova N. B. Mataev S. I., Vasil’kova T. N., Troshina I. A. Metabolic disorders in adipocytokine imbalance and gestational disorder. Ozhirenie i metabolizm [Obesity and Metabolism], 2017, vol. 14, no. 1, pp. 9-16 (in Russian).
9. Pérez-Pérez A., Toro A., Vilariño-García T., Maymó J., Guadix P., Dueñas J. L., Fernández-Sánchez M., Varone C., Sánchez-Margalet V. Leptin action in normal and pathological pregnancies. Journal of Cellular and Molecular Medicine, vol. 22, no. 2, pp. 716-727. DOI: 10.1111/jcmm.13369
10. Manthew H., Castracane V. D., Mantzoros C. S. Adipose tissue and reproductive health. Metabolism, 2017, art. in DOI: 10.1016/j.metabol.2017.11.006
11. Jarvie E., Hauguel-de-Mouzon S., Nelson S. M., Sattar N., Catalano P. M., Freeman D. J. Lipotoxicity in obese pregnancy and its potential role in adverse pregnancy outcome and obesity in the offspring. Clinical Science, 2010, vol. 119, no. 3. DOI: 10.1042/cs20090640
12. Spradley F. T., Palei A. C., Granger J. P. Increased risk for the development of preeclampsia in obese pregnancies: weighing in on the mechanisms. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2015, 309, no. 11, pp. R1326- R1343. DOI: 10.1152/ajpregu.00178.2015
13. Callegari S. B. M., de Resende E. A. M. R., Neto O. B., Junior V. R., de Oliveira E. M., de Fátima Borges M. Obesity and cardiometabolic risk factors during pregnancy. Revista Brasileira de Ginecologia e Obstetrícia, 2014, vol. 36, no. 10, DOI: 10.1590/SO100-720320140004946
14. Gaillard R., Steegers E. A., Franco O. H., Hofman A., Jaddoe V. W. Maternal weight gain in different periods of pregnancy and childhood cardio-metabolic outcomes. The Generation R Study. International Journal of Obesity, 2015, vol. 39, pp. 677-685. DOI: 10.1038/ijo.2014.175
Review
For citations:
Zakharko A.Y., Mitkovskaya N.P., Doronina O.K. OBSTETRICAL PROBLEMS IN PREGNANT WOMEN WITH METABOLIC SYNDROME. Proceedings of the National Academy of Sciences of Belarus, Medical series. 2018;15(2):151-159. (In Russ.) https://doi.org/10.29235/1814-6023-2018-15-2-151-159
Views: 661
Email this article 